Results 231 to 240 of about 272,029 (269)

Evaluating Neurodevelopmental Sequelae of Propranolol Use in Infantile Hemangioma: A Large‐Scale Population‐Based Study

JEADV Clinical Practice, EarlyView.
ABSTRACT Background Propranolol is widely adopted as the first‐line treatment for problematic infantile hemangioma (IH). Despite its efficacy and widespread use, concerns persist about potential long‐term neurodevelopmental risks, given propranolol′s ability to cross the blood‐brain barrier during early development. Objectives To evaluate the long‐term
Khalaf Kridin, Samer Kridin, Wisal Sawaed, Ralf J. Ludwig   +3 more
wiley   +1 more source

Exploring early-stage orienting behavior using an eye tracker for attention deficit hyperactivity disorder classification. [PDF]

Sci Rep
Lee S, Lee S, Jeong I, Jeong J, Park H, Kwon MK, Zanto T, Sul S, Jung D.   +8 more
europepmc   +1 more source

Patient‐Reported Outcomes Selected by Paediatric Patients With Atopic Dermatitis in the Aiming High in Eczema/Atopic Dermatitis Approach

JEADV Clinical Practice, EarlyView.
We surveyed 290 paediatric patients with atopic dermatitis (AD)/their caregivers to determine troublesome AD features described as PROs. The most selected were itch (0‐ to 5‐year‐old children: 85%; children aged ≥ 6 years: 89.3%), skin appearance/condition (69.9% and 61.6%, respectively), and sleep disturbance (38.1% and 25.4%, respectively ...
Yuji Fujita, Sayuri Kajitani, Manabu Miyamoto, Yusuke Ando, Masaya Kato, Hironobu Fukuda, Yumi Yamada, Nozomu Kitahara, Norimasa Fukuda, Hideaki Shiraishi, Shigemi Yoshihara   +10 more
wiley   +1 more source

Population-Level Trends in Attention-Deficit/Hyperactivity Disorder Medication Prescribing.

JAMA Netw Open
Myran DT, MacDonald-Spracklin R, Busa G, Talarico R, Finkelstein Y.   +4 more
europepmc   +1 more source

Sleep disturbances in children and adolescents with attention-deficit/hyperactivity disorder: A narrative review. [PDF]

World J Clin Pediatr
Malhi N, Weiss M, Waxmonsky J, Baweja R.
europepmc   +1 more source

The Mental Health Impact of Retrograde Cricopharyngeus Dysfunction (RCPD) and Its Treatment

The Laryngoscope, EarlyView.
This study assessed the prevalence of anxiety and depression within patients with retrograde cricopharyngeus dysfunction (RCPD) while evaluating the impact of cricopharyngeal botulinum toxin injection (CPBTI) on associated symptoms. Using validated surveys for anxiety and depression given at specific time intervals, RCPD patients were found to have a ...
Alexander P. Simko, Andrew G. Tritter
wiley   +1 more source

Sex differences in the response to treatment of attention deficit hyperactivity disorder. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Müller ED, Fender AC.
europepmc   +1 more source

Clinical Algorithm‐Guided Approach to Botulinum Toxin Type A Treatment for Axial Postural Abnormalities in Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Axial postural abnormalities (APAs) are common, disabling complications of Parkinson's disease (PD) with unclear pathophysiology. The presence of hyperactivity in multiple trunk muscles supports the use of botulinum toxin (BTA). However, its application is complex, due to the lack of standardized clinical and electrophysiological ...
Giacomo Argenziano, Giovanna Squintani, Serena Camozzi, Ilaria Di Vico, Marialuisa Gandolfi, Carlo Alberto Artusi, Michele Tinazzi, Christian Geroin   +7 more
wiley   +1 more source

Attention-deficit/hyperactivity disorder (ADHD) in adults: evidence base, uncertainties and controversies. [PDF]

World Psychiatry
Cortese S, Bellgrove MA, Brikell I, Franke B, Goodman DW, Hartman CA, Larsson H, Levin FR, Ostinelli EG, Parlatini V, Ramos-Quiroga JA, Sibley MH, Tomlinson A, Wilens TE, Wong ICK, Hovén N, Didier J, Correll CU, Rohde LA, Faraone SV.   +19 more
europepmc   +1 more source

Movement Disorders Associated with 22q11.2 Microdeletion: A Scoping Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Movement disorders have recently emerged as important neurologic manifestations of the 22q11.2 microdeletion that affects nearly one in every 2000 live births. Objective We aimed to map the existing evidence regarding the spectrum, diagnosis and treatment, and etiopathogenesis of movement disorders associated with 22q11.2 ...
Nikolai Gil D. Reyes, Daniel G. Di Luca, Connie Marras, Erik Boot, Ryan K.C. Yuen, Anthony E. Lang, Anne S. Bassett   +6 more
wiley   +1 more source